Adam Shlomo Fisch, M.D.,Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Gene Fusion | 3 | 2022 | 371 | 0.960 |
Why?
|
| Nuclear Receptor Coactivators | 1 | 2021 | 59 | 0.770 |
Why?
|
| Proto-Oncogene Proteins c-ret | 2 | 2023 | 220 | 0.740 |
Why?
|
| Pathology, Molecular | 1 | 2022 | 326 | 0.680 |
Why?
|
| Salivary Gland Neoplasms | 1 | 2021 | 298 | 0.600 |
Why?
|
| Gene Rearrangement | 2 | 2021 | 1179 | 0.560 |
Why?
|
| Brachial Artery | 1 | 2015 | 369 | 0.470 |
Why?
|
| Carcinoma, Intraductal, Noninfiltrating | 1 | 2021 | 949 | 0.460 |
Why?
|
| Amyloidosis | 1 | 2020 | 795 | 0.440 |
Why?
|
| Ticlopidine | 3 | 2013 | 899 | 0.420 |
Why?
|
| Aryl Hydrocarbon Hydroxylases | 1 | 2012 | 257 | 0.380 |
Why?
|
| Platelet Aggregation Inhibitors | 2 | 2013 | 3068 | 0.350 |
Why?
|
| Platelet Aggregation | 1 | 2012 | 798 | 0.330 |
Why?
|
| Receptors, Cell Surface | 1 | 2015 | 2866 | 0.270 |
Why?
|
| Esthesioneuroblastoma, Olfactory | 1 | 2023 | 56 | 0.220 |
Why?
|
| Endothelial Cells | 1 | 2015 | 3479 | 0.220 |
Why?
|
| Precursor B-Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2023 | 222 | 0.200 |
Why?
|
| Bone Cysts | 1 | 2021 | 47 | 0.190 |
Why?
|
| High-Throughput Nucleotide Sequencing | 3 | 2022 | 3597 | 0.190 |
Why?
|
| Paranasal Sinus Neoplasms | 1 | 2023 | 234 | 0.190 |
Why?
|
| Nose Neoplasms | 1 | 2023 | 246 | 0.190 |
Why?
|
| Algorithms | 1 | 2021 | 13881 | 0.190 |
Why?
|
| Proto-Oncogene Proteins c-ets | 1 | 2021 | 318 | 0.180 |
Why?
|
| Hemorrhage | 1 | 2012 | 3461 | 0.180 |
Why?
|
| Oncogene Fusion | 1 | 2020 | 99 | 0.180 |
Why?
|
| RNA-Binding Protein EWS | 1 | 2021 | 216 | 0.180 |
Why?
|
| Cardiovascular Diseases | 3 | 2015 | 15165 | 0.170 |
Why?
|
| Adenocarcinoma, Follicular | 1 | 2023 | 324 | 0.170 |
Why?
|
| Thrombosis | 1 | 2013 | 2968 | 0.170 |
Why?
|
| Lung Neoplasms | 2 | 2023 | 13102 | 0.170 |
Why?
|
| Sarcoma | 2 | 2021 | 1897 | 0.170 |
Why?
|
| Humerus | 1 | 2021 | 266 | 0.170 |
Why?
|
| NFATC Transcription Factors | 1 | 2021 | 381 | 0.170 |
Why?
|
| Fibula | 1 | 2021 | 269 | 0.160 |
Why?
|
| Anticoagulants | 1 | 2013 | 4599 | 0.160 |
Why?
|
| Myeloid-Lymphoid Leukemia Protein | 1 | 2020 | 294 | 0.150 |
Why?
|
| Neoplasms | 2 | 2023 | 21683 | 0.140 |
Why?
|
| Liver Neoplasms | 2 | 2023 | 4253 | 0.140 |
Why?
|
| Histone-Lysine N-Methyltransferase | 1 | 2020 | 670 | 0.130 |
Why?
|
| Femur | 1 | 2021 | 1297 | 0.120 |
Why?
|
| Aryldialkylphosphatase | 1 | 2011 | 63 | 0.100 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2023 | 2214 | 0.100 |
Why?
|
| Soft Tissue Neoplasms | 1 | 2020 | 1363 | 0.090 |
Why?
|
| Repressor Proteins | 1 | 2021 | 3023 | 0.090 |
Why?
|
| Thyroid Neoplasms | 1 | 2023 | 2282 | 0.090 |
Why?
|
| Carcinoma | 1 | 2021 | 2375 | 0.090 |
Why?
|
| Genetic Variation | 2 | 2015 | 6544 | 0.080 |
Why?
|
| Immunohistochemistry | 1 | 2021 | 11366 | 0.070 |
Why?
|
| Humans | 17 | 2023 | 744343 | 0.070 |
Why?
|
| Databases, Factual | 1 | 2021 | 7729 | 0.070 |
Why?
|
| Predictive Value of Tests | 1 | 2021 | 15076 | 0.060 |
Why?
|
| Middle Aged | 7 | 2023 | 213383 | 0.060 |
Why?
|
| Melanoma | 1 | 2023 | 5510 | 0.060 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 1 | 2023 | 5221 | 0.060 |
Why?
|
| Warfarin | 1 | 2013 | 1496 | 0.060 |
Why?
|
| Diagnosis, Differential | 1 | 2020 | 12959 | 0.060 |
Why?
|
| Lipid Peroxides | 1 | 2023 | 73 | 0.060 |
Why?
|
| Skin Neoplasms | 1 | 2023 | 5686 | 0.060 |
Why?
|
| Adult | 5 | 2022 | 214055 | 0.060 |
Why?
|
| Cell Movement | 1 | 2015 | 5217 | 0.060 |
Why?
|
| Oxyphil Cells | 1 | 2023 | 57 | 0.060 |
Why?
|
| Fermentation | 1 | 2023 | 144 | 0.060 |
Why?
|
| Genetic Association Studies | 1 | 2011 | 2703 | 0.050 |
Why?
|
| Female | 8 | 2023 | 380194 | 0.050 |
Why?
|
| Male | 9 | 2023 | 350118 | 0.050 |
Why?
|
| Nasal Cavity | 1 | 2023 | 313 | 0.050 |
Why?
|
| Neoplasm Recurrence, Local | 3 | 2023 | 9239 | 0.050 |
Why?
|
| Epithelioid Cells | 1 | 2020 | 71 | 0.040 |
Why?
|
| Iodine Radioisotopes | 1 | 2023 | 1032 | 0.040 |
Why?
|
| Protein Isoforms | 1 | 2023 | 1730 | 0.040 |
Why?
|
| DNA, Mitochondrial | 1 | 2023 | 817 | 0.040 |
Why?
|
| Gene Expression Regulation | 1 | 2015 | 12072 | 0.040 |
Why?
|
| Thyroid Gland | 1 | 2023 | 1173 | 0.030 |
Why?
|
| Aged, 80 and over | 1 | 2021 | 57776 | 0.030 |
Why?
|
| Aged | 4 | 2023 | 163280 | 0.030 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 1 | 2023 | 1692 | 0.030 |
Why?
|
| Sequence Analysis, RNA | 1 | 2023 | 2012 | 0.030 |
Why?
|
| Child | 1 | 2022 | 77709 | 0.030 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2015 | 17446 | 0.030 |
Why?
|
| Proto-Oncogene Proteins B-raf | 1 | 2023 | 2043 | 0.030 |
Why?
|
| Homeodomain Proteins | 1 | 2021 | 2421 | 0.020 |
Why?
|
| Treatment Outcome | 2 | 2013 | 63114 | 0.020 |
Why?
|
| Antibodies, Viral | 1 | 2020 | 3176 | 0.020 |
Why?
|
| Mutation | 2 | 2023 | 29786 | 0.020 |
Why?
|
| Genomics | 1 | 2023 | 5720 | 0.020 |
Why?
|
| Hospitals | 1 | 2020 | 3952 | 0.020 |
Why?
|
| Disease Progression | 1 | 2023 | 13284 | 0.020 |
Why?
|
| Nuclear Proteins | 1 | 2021 | 5853 | 0.020 |
Why?
|
| Sensitivity and Specificity | 1 | 2020 | 14722 | 0.020 |
Why?
|
| Young Adult | 2 | 2021 | 56430 | 0.010 |
Why?
|
| Neurons | 1 | 2023 | 9338 | 0.010 |
Why?
|
| Retrospective Studies | 2 | 2023 | 77449 | 0.010 |
Why?
|
| Prognosis | 1 | 2023 | 29063 | 0.010 |
Why?
|
| Transcription Factors | 1 | 2021 | 12208 | 0.010 |
Why?
|
| Child, Preschool | 1 | 2021 | 41006 | 0.010 |
Why?
|
| Survival Rate | 1 | 2011 | 12788 | 0.010 |
Why?
|
| Mice | 1 | 2023 | 81183 | 0.010 |
Why?
|
| Adolescent | 1 | 2021 | 85781 | 0.010 |
Why?
|
| Animals | 1 | 2023 | 168757 | 0.010 |
Why?
|
| Follow-Up Studies | 1 | 2011 | 39050 | 0.010 |
Why?
|
| Cohort Studies | 1 | 2011 | 40561 | 0.010 |
Why?
|